Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Algernon, Arcturus, Ascentage, Ascletis, Astellas, Athersys, Beigene, Bellerophon, Biohaven, Calcimedica, Can-Fite, Hope, Predictive, Ridgeback.